Publications

Publications by Frode Vartdal

157 publications found

Publications 2019

  1. Tomescu-Baciu A, Johansen JN, Holmøy T, Greiff V, Stensland M, de Souza GA, Vartdal F, Lossius A (2019)
    Persistence of intrathecal oligoclonal B cells and IgG in multiple sclerosis
    J Neuroimmunol, 333, 576966
    DOI 10.1016/j.jneuroim.2019.576966, PubMed 31153015

Publications 2018

  1. Høglund RA, Polak J, Vartdal F, Holmøy T, Lossius A (2018)
    B-cell composition in the blood and cerebrospinal fluid of multiple sclerosis patients treated with dimethyl fumarate
    Mult Scler Relat Disord, 26, 90-95
    DOI 10.1016/j.msard.2018.08.032, PubMed 30243235
  2. Tomescu-Baciu A, Vartdal F, Holmøy T, Vedeler CA, Lossius A (2018)
    G1m1 predominance of intrathecal virus-specific antibodies in multiple sclerosis
    Ann Clin Transl Neurol, 5 (10), 1303-1309
    DOI 10.1002/acn3.642, PubMed 30349866
  3. Vartdal F (2018)
    Congratulations on your study choice!
    Tidsskr. Nor. Laegeforen., 138 (12), 1201

Publications 2017

  1. Lossius A, Tomescu-Baciu A, Holmøy T, Vedeler CA, Røsjø E, Lorentzen ÅR, Casetta I, Vartdal F (2017)
    Selective intrathecal enrichment of G1m1-positive B cells in multiple sclerosis
    Ann Clin Transl Neurol, 4 (10), 756-761
    DOI 10.1002/acn3.451, PubMed 29046884

Publications 2016

  1. Lossius A, Johansen JN, Vartdal F, Holmøy T (2016)
    High-throughput sequencing of immune repertoires in multiple sclerosis
    Ann Clin Transl Neurol, 3 (4), 295-306
    DOI 10.1002/acn3.295, PubMed 27081660

Publications 2015

  1. Johansen JN, Vartdal F, Desmarais C, Tutturen AE, de Souza GA, Lossius A, Holmøy T (2015)
    Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: Equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome
    Clin Immunol, 160 (2), 211-25
    DOI 10.1016/j.clim.2015.06.001, PubMed 26055752

Publications 2014

  1. Lossius A, Johansen JN, Vartdal F, Robins H, Jūratė Šaltytė B, Holmøy T, Olweus J (2014)
    High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells
    44 (11), 3439-52
    DOI 10.1002/eji.201444662, PubMed 25103993
  2. Vartdal F (2014)
    [In accordance with the law]
    134 (3), 267
    DOI 10.4045/tidsskr.14.0078, PubMed 24518453

Publications 2012

  1. Lossius A, Johansen JN, Torkildsen Ø, Vartdal F, Holmøy T (2012)
    Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation
    Viruses, 4 (12), 3701-30
    DOI 10.3390/v4123701, PubMed 23342374

Publications 2011

  1. Lossius A, Vartdal F, Holmøy T (2011)
    Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis
    J Neuroimmunol, 240-241, 87-96
    DOI 10.1016/j.jneuroim.2011.09.011, PubMed 22018702

Publications 2010

  1. Smeland EB, Vartdal F, Wisløff F (2010)
    [Close cooperation, but not oversteering]
    130 (6), 590-1
    DOI 10.4045/tidsskr.10.0153, PubMed 20348990
  2. Smeland EB, Vartdal F, Wisløff F (2010)
    [Leadership and academic competence]
    130 (6), 591
    DOI 10.4045/tidsskr.10.0217, PubMed 20348994

Publications 2009

  1. Hestvik AL, Skorstad G, Vartdal F, Holmøy T (2009)
    Idiotope-specific CD4(+) T cells induce apoptosis of human oligodendrocytes
    J Autoimmun, 32 (2), 125-32
    DOI 10.1016/j.jaut.2009.01.004, PubMed 19250800
  2. Holmøy T, Harbo H, Vartdal F, Spurkland A (2009)
    Genetic and molecular approaches to the immunopathogenesis of multiple sclerosis: an update
    Curr Mol Med, 9 (5), 591-611
    DOI 10.2174/156652409788488793, PubMed 19601809
  3. Holmøy T, Skorstad G, Hestvik AL, Alvik KM, Vartdal F (2009)
    Protective and detrimental immunity: lessons from stiff person syndrome and multiple sclerosis
    (189), 22-6
    DOI 10.1111/j.1600-0404.2009.01207.x, PubMed 19566493
  4. Holmøy T, Vartdal F, Hestvik AL, Munthe L, Bogen B (2009)
    The idiotype connection: linking infection and multiple sclerosis
    Trends Immunol, 31 (2), 56-62
    DOI 10.1016/j.it.2009.11.001, PubMed 19962346
  5. Skorstad G, Vandvik B, Vartdal F, Holmøy T (2009)
    MS and clinically isolated syndromes: shared specificity but diverging clonal patterns of virus-specific IgG antibodies produced in vivo and by CSF B cells in vitro
    Eur J Neurol, 16 (10), 1124-9
    DOI 10.1111/j.1468-1331.2009.02657.x, PubMed 19469834

Publications 2008

  1. Hestvik AL, Skorstad G, Price DA, Vartdal F, Holmoy T (2008)
    Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid
    Mult Scler, 14 (6), 749-58
    DOI 10.1177/1352458508089411, PubMed 18611988
  2. Lorentzen AR, Smestad C, Lie BA, Oturai AB, Akesson E, Saarela J, Myhr KM, Vartdal F, Celius EG, Sørensen PS, Hillert J, Spurkland A, Harbo HF (2008)
    The SH2D2A gene and susceptibility to multiple sclerosis
    J Neuroimmunol, 197 (2), 152-8
    DOI 10.1016/j.jneuroim.2008.04.037, PubMed 18554728
  3. Skorstad G, Hestvik AL, Torjesen P, Alvik K, Vartdal F, Vandvik B, Holmøy T (2008)
    GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence
    Eur J Neurol, 15 (9), 973-80
    DOI 10.1111/j.1468-1331.2008.02221.x, PubMed 18637036
  4. Skorstad G, Hestvik AL, Vartdal F, Holmøy T (2008)
    Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome
    J Autoimmun, 32 (1), 24-32
    DOI 10.1016/j.jaut.2008.10.002, PubMed 19027267

Publications 2007

  1. Hestvik AL, Vartdal F, Fredriksen AB, Thompson KM, Kvale EO, Skorstad G, Bogen B, Holmoy T (2007)
    T cells from multiple sclerosis patients recognize multiple epitopes on Self-IgG
    66 (4), 393-401
    DOI 10.1111/j.1365-3083.2007.01955.x, PubMed 17850583
  2. Holmøy T, Vartdal F (2007)
    The immunological basis for treatment of multiple sclerosis
    66 (4), 374-82
    DOI 10.1111/j.1365-3083.2007.01982.x, PubMed 17850581

Publications 2006

  1. Holmøy T, Hestvik AL, Vartdal F (2006)
    Towards individualised multiple sclerosis treatment
    Lancet Neurol, 5 (2), 111-2
    DOI 10.1016/S1474-4422(06)70334-9, PubMed 16426986
  2. Holmøy T, Hestvik AL, Vartdal F (2006)
    Management of progressive multifocal leukoencephalopathy associated with natalizumab--possibilities and responsibility
    Eur J Neurol, 13 (8), e2
    DOI 10.1111/j.1468-1331.2006.01555.x, PubMed 16879280

Publications 2005

  1. Holmøy T, Fredriksen AB, Thompson KM, Hestvik AL, Bogen B, Vartdal F (2005)
    Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells
    35 (6), 1786-94
    DOI 10.1002/eji.200425417, PubMed 15864781
  2. Holmøy T, Vartdal F (2005)
    Infectious causes of multiple sclerosis
    Lancet Neurol, 4 (5), 268; discussion 269
    DOI 10.1016/S1474-4422(05)70054-5, PubMed 15847838
  3. Lorentzen AR, Celius EG, Ekstrøm PO, Wiencke K, Lie BA, Myhr KM, Ling V, Thorsby E, Vartdal F, Spurkland A, Harbo HF (2005)
    Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients
    J Neuroimmunol, 166 (1-2), 197-201
    DOI 10.1016/j.jneuroim.2005.06.002, PubMed 16005527

Publications 2004

  1. Dai KZ, Johansen FE, Kolltveit KM, Aasheim HC, Dembic Z, Vartdal F, Spurkland A (2004)
    Transcriptional activation of the SH2D2A gene is dependent on a cyclic adenosine 5'-monophosphate-responsive element in the proximal SH2D2A promoter
    172 (10), 6144-51
    DOI 10.4049/jimmunol.172.10.6144, PubMed 15128801
  2. Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, Oturai A, Hillert J, Lorentzen AR, Laaksonen M, Myhr KM, Ryder LP, Fredrikson S, Nyland H, Sørensen PS, Sandberg-Wollheim M, Andersen O, Svejgaard A, Edland A, Mellgren SI, Compston A, Vartdal F, Spurkland A (2004)
    Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis
    63 (3), 237-47
    DOI 10.1111/j.0001-2815.2004.00173.x, PubMed 14989713
  3. Holmøy T, Kvale EØ, Vartdal F (2004)
    Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein
    J Neurovirol, 10 (5), 278-83
    DOI 10.1080/13550280490499524, PubMed 15385250
  4. Holmøy T, Vartdal F (2004)
    Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells
    J Neurovirol, 10 (1), 52-6
    DOI 10.1080/13550280490261671, PubMed 14982728

Publications 2003

  1. Etokebe GE, Opsahl M, Tveter AK, Lie BA, Thorsby E, Vartdal F, Spurkland A (2003)
    Physical separation of HLA-A alleles by denaturing high-performance liquid chromatography
    61 (6), 443-50
    DOI 10.1034/j.1399-0039.2003.00058.x, PubMed 12823768
  2. Gregers TF, Fleckenstein B, Vartdal F, Roepstorff P, Bakke O, Sandlie I (2003)
    MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation
    Int Immunol, 15 (11), 1291-9
    DOI 10.1093/intimm/dxg128, PubMed 14565927
  3. Harbo HF, Datta P, Oturai A, Ryder LP, Sawcer S, Setakis E, Akesson E, Celius EG, Modin H, Sandberg-Wollheim M, Myhr KM, Andersen O, Hillert J, Sorensen PS, Svejgaard A, Compston A, Vartdal F, Spurkland A (2003)
    Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients
    J Neuroimmunol, 143 (1-2), 101-6
    DOI 10.1016/j.jneuroim.2003.08.021, PubMed 14575924
  4. Holmøy T, Vandvik B, Vartdal F (2003)
    T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid
    Mult Scler, 9 (3), 228-34
    DOI 10.1191/1352458503ms906oa, PubMed 12814167

Publications 2001

  1. Dai KZ, Harbo HF, Celius EG, Oturai A, Sørensen PS, Ryder LP, Datta P, Svejgaard A, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Myhr KM, Nyland H, Vartdal F, Spurkland A (2001)
    The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis
    Genes Immun, 2 (5), 263-8
    DOI 10.1038/sj.gene.6363774, PubMed 11528519
  2. Modin H, Dai Y, Masterman T, Svejgaard A, Sørensen PS, Oturai A, Ryder LP, Spurkland A, Vartdal F, Laaksonen M, Sandberg-Wollheim M, Myhr KM, Nyland H, Hillert J (2001)
    No linkage or association of the nitric oxide synthase genes to multiple sclerosis
    J Neuroimmunol, 119 (1), 95-100
    DOI 10.1016/s0165-5728(01)00366-6, PubMed 11525805
  3. Vartdal F (2001)
    Genetic background for immune-mediated diseases
    59 (4), 212-5
    DOI 10.1080/00016350152509229, PubMed 11570523

Publications 2000

  1. Celius EG, Harbo HF, Egeland T, Vartdal F, Vandvik B, Spurkiand A (2000)
    Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis
    178 (2), 132-5
    DOI 10.1016/s0022-510x(00)00389-0, PubMed 11018705

Publications 1999

  1. Harbo HF, Celius EG, Vartdal F, Spurkland A (1999)
    CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis
    53 (1), 106-10
    DOI 10.1034/j.1399-0039.1999.530112.x, PubMed 10082437
  2. Harbo HF, Celius EG, Vartdal F, Spurkland A (1999)
    CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis
    Tissue Antigens, 53 (1), 106-110
  3. Leivestad T, Reisaeter AV, Brekke IB, Vartdal F, Thorsby E (1999)
    The role of HLA matching in renal transplantation: experience from one center
    Rev Immunogenet, 1 (3), 343-50
    PubMed 11256425
  4. Vartdal F, Thorsby E (1999)
    Transplantation immunology--the role of human leucocyte antigen in allorecognition
    92, 1-18
    PubMed 9919804
  5. Vartdal F, Thorsby E (1999)
    [Immunologic reactions in transplantation]
    119 (21), 3167-70
    PubMed 10522486

Publications 1998

  1. Fossum S, Vartdal F (1998)
    [The medical prize of Anders Jahre 1998]
    160 (52), 7620-1
    PubMed 9889687
  2. Reisaeter AV, Leivestad T, Vartdal F, Spurkland A, Fauchald P, Brekke IB, Thorsby E (1998)
    A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: a single-center study of first cadaveric kidneys to nonsensitized recipients
    66 (4), 523-8
    DOI 10.1097/00007890-199808270-00018, PubMed 9734498
  3. Spurkland A, Brinchmann JE, Markussen G, Pedeutour F, Munthe E, Lea T, Vartdal F, Aasheim HC (1998)
    Molecular cloning of a T cell-specific adapter protein (TSAd) containing an Src homology (SH) 2 domain and putative SH3 and phosphotyrosine binding sites
    273 (8), 4539-46
    DOI 10.1074/jbc.273.8.4539, PubMed 9468509
  4. Straumfors A, Johansen BH, Vartdal F, Sollid LM, Thorsby E, Buus S (1998)
    A peptide-binding assay for the disease-associated HLA-DQ8 molecule
    47 (6), 561-7
    DOI 10.1046/j.1365-3083.1998.00342.x, PubMed 9652824
  5. Straumfors A, Johansen BH, Vartdal F, Sollid LM, Thorsby E, Buus S (1998)
    A peptide-binding assay for the disease-associated HLA-DQ8 molecule
    Scand. J. Immunol., 47 (6), 561-567
  6. Vartdal F (1998)
    Erik Thorsby is 60
    52 (1), 96-8
    DOI 10.1111/j.1399-0039.1998.tb03032.x, PubMed 9714483

Publications 1997

  1. Sollid LM, Johansen BH, Lundin KEA, Molberg O, Scott H, Sjostrom H, Thorpe CJ, Vartdal F, Thorsby E (1997)
    The molecular basis of the HLA association in celiac disease: A model for other HLA-associated diseases
    ALFRED BENZON SYMP S, 40, 362-377
  2. Sollid LM, Johansen BH, Lundin KEA, Molberg O, Scott H, Vartdal F, Thorsby E (1997)
    The molecular basis of the HLA association in celiac disease - A model disease for type 1 diabetes and other HLA associated diseases
    NATO ASI 3 HIGH TECH, 35, 61-69
  3. Spurkland A, Celius EG, Knutsen I, Beiske A, Thorsby E, Vartdal F (1997)
    The HLA-DQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01, beta 1*1501) heterodimer
    50 (1), 15-22
    DOI 10.1111/j.1399-0039.1997.tb02828.x, PubMed 9243750
  4. Vartdal F, Johansen BH, Friede T, Thorpe CJ, Stevanovic S, Eriksen JA, Sletten K, Rammensee HG, Thorsby E, Sollid LM (1997)
    Motif for HLA-DQ2 (alpha 1*0501, beta 1*0201): anchors at P1, P4, P6, P7 and P9
    HLA - GENETIC DIVERSITY OF HLA FUNCTIONAL AND MEDICAL IMPLICATION, PROCEEDINGS OF THE TWELFTH INTERNATIONAL HISTOCOMPATIBILITY WORKSHOP AND CONFERENCE (12TH IHWC), VOL II: CONFERENCE, 431-432

Publications 1996

  1. Johansen BH, Gjertsen HA, Vartdal F, Buus S, Thorsby E, Lundin KE, Sollid LM (1996)
    Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays
    79 (3), 288-93
    DOI 10.1006/clin.1996.0081, PubMed 8635288
  2. Johansen BH, Jensen T, Thorpe CJ, Vartdal F, Thorsby E, Sollid LM (1996)
    Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential
    45 (2), 142-50
    DOI 10.1007/s002510050182, PubMed 8952964
  3. Johansen BH, Vartdal F, Eriksen JA, Thorsby E, Sollid LM (1996)
    Identification of a putative motif for binding of peptides to HLA-DQ2
    Int Immunol, 8 (2), 177-82
    DOI 10.1093/intimm/8.2.177, PubMed 8671602
  4. Vartdal F, Johansen BH, Friede T, Thorpe CJ, Stevanović S, Eriksen JE, Sletten K, Thorsby E, Rammensee HG, Sollid LM (1996)
    The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule
    26 (11), 2764-72
    DOI 10.1002/eji.1830261132, PubMed 8921967

Publications 1995

  1. LEIVESTAD T, SPURKLAND A, KNUTSEN I, BRATLIE A, VARTDAL F, PFEFFER P, SODAL G, FAUCHALD P, THORSBY E (1995)
    GENOMIC HLA-DRB1 MATCHING FURTHER IMPROVES CLINICAL COURSE AFTER RENAL-TRANSPLANTATION
    Transplant. Proc., 27 (1), 678-679
  2. Leivestad T, Spurkland A, Knutsen I, Bratlie A, Vartdal F, Pfeffer P, Sødal G, Fauchald P, Thorsby E (1995)
    Genomic HLA-DRB1 matching further improves clinical course after renal transplantation
    27 (1), 678-9
    PubMed 7879142

Publications 1994

  1. Johansen BH, Buus S, Vartdal F, Viken H, Eriksen JA, Thorsby E, Sollid LM (1994)
    Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(alpha 1*0501, beta 1*0201) molecule
    Int Immunol, 6 (3), 453-61
    DOI 10.1093/intimm/6.3.453, PubMed 8186196
  2. Johansen BH, Gedde-Dahl T, Sollid LM, Vartdal F, Thorsby E, Gaudernack G (1994)
    Binding of ras oncogene peptides to purified HLA-DQ(alpha 1*0102,beta 1*0602) and -DR(alpha,beta 1*0101) molecules
    39 (6), 607-12
    DOI 10.1111/j.1365-3083.1994.tb03420.x, PubMed 8009176
  3. Johansen BH, Gedde-Dahl T, Sollid LM, Vartdal F, Thorsby E, Gaudernack G (1994)
    Binding of ras oncogene peptides to purified HLA-DQ (alpha 1*0102, beta 1*0602) and -DR (alpha, beta 1*0101) molecules
    40 (4), 468
    DOI 10.1111/j.1365-3083.1994.tb03491.x, PubMed 7939420
  4. Spurkland A, Gedde-Dahl T, Hansen T, Vartdal F, Gaudernack G, Thorsby E (1994)
    Heterogeneity of T cells specific for a particular peptide/HLA-DQ complex
    39 (1), 61-8
    DOI 10.1016/0198-8859(94)90102-3, PubMed 8181964
  5. Spurkland A, Knutsen I, Undlien DE, Vartdal F (1994)
    No association of multiple sclerosis to alleles at the TAP2 locus
    39 (4), 299-301
    DOI 10.1016/0198-8859(94)90273-9, PubMed 8071104

Publications 1993

  1. LEIVESTAD T, SODAL G, BRATLIE A, ALBRECHTSEN D, FAUCHALD P, PFEFFER P, VARTDAL F, THORSBY E (1993)
    ROLE OF HLA MATCHING IN CADAVERIC RENAL-TRANSPLANTATION - INFLUENCE OF IMPROVED SEROLOGIC HLA-DR TYPING
    Transplant. Proc., 25 (1), 220-221
  2. Leivestad T, Sødal G, Bratlie A, Albrechtsen D, Fauchald P, Pfeffer P, Vartdal F, Thorsby E (1993)
    Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing
    25 (1 Pt 1), 220-1
    PubMed 8438277
  3. Ploski R, Vinje O, Rønningen KS, Spurkland A, Sørskaar D, Vartdal F, Førre O (1993)
    HLA class II alleles and heterogeneity of juvenile rheumatoid arthritis. DRB1*0101 may define a novel subset of the disease
    36 (4), 465-72
    DOI 10.1002/art.1780360406, PubMed 8457222
  4. Spurkland A, Knutsen I, Markussen G, Vartdal F, Egeland T, Thorsby E (1993)
    HLA matching of unrelated bone marrow transplant pairs: direct sequencing of in vitro amplified HLA-DRB1 and -DQB1 genes using magnetic beads as solid support
    41 (3), 155-64
    DOI 10.1111/j.1399-0039.1993.tb01995.x, PubMed 8316946

Publications 1992

  1. BRINCHMANN JE, GAUDERNACK G, THORSBY E, VARTDAL F (1992)
    STAPHYLOCOCCAL EXOTOXIN SUPERANTIGENS INDUCE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EXPRESSION IN NATURALLY INFECTED CD4+ T-CELLS
    J. Virol., 66 (10), 5924-5928
  2. Brinchmann JE, Gaudernack G, Thorsby E, Vartdal F (1992)
    Staphylococcal exotoxin superantigens induce human immunodeficiency virus type 1 expression in naturally infected CD4+ T cells
    66 (10), 5924-8
    PubMed 1356159
  3. SPURKLAND A, RONNINGEN KS, LEIVESTAD T, VARTDAL F, THORSBY E (1992)
    HLA-DR HLA-DQ HAPLOTYPE FREQUENCIES IN A NORWEGIAN POPULATION
    Transplant. Proc., 24 (1), 298-299
  4. Spurkland A, Rønningen KS, Leivestad T, Vartdal F, Thorsby E (1992)
    HLA-DR-DQ haplotype frequencies in a Norwegian population
    24 (1), 298-9
    PubMed 1539285
  5. Spurkland A, Sollid LM, Polanco I, Vartdal F, Thorsby E (1992)
    HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7
    35 (3), 188-92
    DOI 10.1016/0198-8859(92)90104-u, PubMed 1293082
  6. Spurkland A, Vartdal F (1992)
    Linkage disequilibrium between DPA1 and DPB1 alleles among Norwegian Caucasoids and Japanese
    40 (1), 1-4
    DOI 10.1111/j.1399-0039.1992.tb01950.x, PubMed 1440558

Publications 1991

  1. Brinchmann JE, Albert J, Vartdal F (1991)
    Few infected CD4+ T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection
    65 (4), 2019-23
    PubMed 1672165
  2. BRINCHMANN JE, ALBERT J, VARTDAL F (1991)
    FEW INFECTED CD4+ T-CELLS BUT A HIGH PROPORTION OF REPLICATION-COMPETENT PROVIRUS COPIES IN ASYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    J. Virol., 65 (4), 2019-2023
  3. Brinchmann JE, Gaudernack G, Vartdal F (1991)
    In vitro replication of HIV-1 in naturally infected CD4+ T cells is inhibited by rIFN alpha 2 and by a soluble factor secreted by activated CD8+ T cells, but not by rIFN beta, rIFN gamma, or recombinant tumor necrosis factor-alpha
    J Acquir Immune Defic Syndr, 4 (5), 480-8
    PubMed 1673156
  4. Brinchmann JE, Vartdal F, Thorsby E, Bucher A, Frøland SS, Kittelsen P, Kristoffersen J, Baklien K (1991)
    [Quantification of T-lymphocyte subpopulations. Immunological marker in human immunodeficiency virus infections]
    111 (4), 440-3
    PubMed 2006482
  5. Ronningen KS, Spurkland A, Iwe T, Sollid LM, Vartdal F, Thorsby E (1991)
    Novel HLA-DR2 and -DR3 haplotypes among Norwegian Caucasians
    37 (4), 165-7
    DOI 10.1111/j.1399-0039.1991.tb01866.x, PubMed 1926125
  6. RONNINGEN KS, SPURKLAND A, IWE T, SOLLID LM, VARTDAL F, THORSBY E (1991)
    NOVEL HLA-DR2 AND -DR3 HAPLOTYPES AMONG NORWEGIAN CAUCASIANS
    Tissue Antigens, 37 (4), 165-167
  7. Rønningen KS, Spurkland A, Iwe T, Vartdal F, Thorsby E (1991)
    Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus
    37 (3), 105-11
    DOI 10.1111/j.1399-0039.1991.tb01854.x, PubMed 1908143
  8. Spurkland A, Gilhus NE, Rønningen KS, Aarli JA, Vartdal F (1991)
    Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations
    37 (2), 90-3
    DOI 10.1111/j.1399-0039.1991.tb01851.x, PubMed 2057938
  9. Spurkland A, Rønningen KS, Vandvik B, Thorsby E, Vartdal F (1991)
    HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis
    30 (1), 69-75
    DOI 10.1016/0198-8859(91)90073-i, PubMed 2001977
  10. Spurkland A, Tabira T, Rønningen KS, Vandvik B, Thorsby E, Vartdal F (1991)
    HLA-DRB1, -DQA1, -DQB1, -DPA1 and -DPB1 genes in Japanese multiple sclerosis patients
    37 (4), 171-3
    DOI 10.1111/j.1399-0039.1991.tb01868.x, PubMed 1926126

Publications 1990

  1. ALBRECHTSEN D, GEIRAN O, FOERSTER A, FAUCHALD P, FLESLAND O, LINDBERG H, SOLHEIM BG, VARTDAL F, FROYSAKER T (1990)
    CARDIAC TRANSPLANTATION FROM A BLOOD GROUP-ABO-INCOMPATIBLE DONOR - A CASE-REPORT
    Transplant. Proc., 22 (1), 143
  2. Albrechtsen D, Geiran O, Foerster A, Fauchald P, Flesland O, Lindberg H, Solheim BG, Vartdal F, Frøysaker T (1990)
    Cardiac transplantation from a blood group ABO-incompatible donor: a case report
    22 (1), 143
    PubMed 2309290
  3. BRINCHMANN JE, GAUDERNACK G, VARTDAL F (1990)
    CD8+ T-CELLS INHIBIT HIV REPLICATION IN NATURALLY INFECTED CD4+ T-CELLS - EVIDENCE FOR A SOLUBLE INHIBITOR
    J. Immunol., 144 (8), 2961-2966
  4. Brinchmann JE, Gaudernack G, Vartdal F (1990)
    CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor
    144 (8), 2961-6
    PubMed 1969879
  5. Jakobsen A, Albrechtsen D, Sødal G, Flatmark A, Fauchald P, Vartdal F (1990)
    [Costs of care in uremia. How much does kidney transplantation cost?]
    110 (3), 338-41
    PubMed 2309175
  6. LEIVESTAD T, ALBRECHTSEN D, BRATLIE A, JAKOBSEN A, PFEFFER P, SODAL G, VARTDAL F, FLATMARK A, THORSBY E (1990)
    THE ROLE OF HLA COMPATIBILITY IN RENAL-TRANSPLANTATION FROM LIVING DONORS - AN ANALYSIS OF 379 GRAFTS
    Transplant. Proc., 22 (1), 153
  7. Leivestad T, Albrechtsen D, Bratlie A, Jakobsen A, Pfeffer P, Sødal G, Vartdal F, Flatmark A, Thorsby E (1990)
    The role of HLA compatibility in renal transplantation from living donors: an analysis of 379 grafts
    22 (1), 153
    PubMed 2309293
  8. Mellbye OJ, Vartdal F, Pahle J, Mollnes TE (1990)
    IgG and IgA subclass distribution of total immunoglobulin and rheumatoid factors in rheumatoid tissue plasma cells
    19 (5), 333-40
    DOI 10.3109/03009749009096788, PubMed 2218430
  9. Rønningen KS, Spurkland A, Egeland T, Iwe T, Munthe E, Vartdal F, Thorsby E (1990)
    Rheumatoid arthritis may be primarily associated with HLA-DR4 molecules sharing a particular sequence at residues 67-74
    36 (5), 235-40
    DOI 10.1111/j.1399-0039.1990.tb01834.x, PubMed 2095004
  10. Rønningen KS, Spurkland A, Markussen G, Iwe T, Vartdal F, Thorsby E (1990)
    Distribution of HLA class II alleles among Norwegian Caucasians
    29 (4), 275-81
    DOI 10.1016/0198-8859(90)90041-m, PubMed 2286539
  11. Spurkland A, Sollid LM, Rønningen KS, Bosnes V, Ek J, Vartdal F, Thorsby E (1990)
    Susceptibility to develop celiac disease is primarily associated with HLA-DQ alleles
    29 (3), 157-65
    DOI 10.1016/0198-8859(90)90111-2, PubMed 1980918

Publications 1989

  1. Brinchmann JE, Gaudernack G, Thorsby E, Jonassen TO, Vartdal F (1989)
    Reliable isolation of human immunodeficiency virus from cultures of naturally infected CD4+ T cells
    25 (3), 293-300
    DOI 10.1016/0166-0934(89)90056-6, PubMed 2573612
  2. BRINCHMANN JE, LEIVESTAD T, VARTDAL F (1989)
    QUANTIFICATION OF LYMPHOCYTE SUBSETS BASED ON POSITIVE IMMUNOMAGNETIC SELECTION OF CELLS DIRECTLY FROM BLOOD
    J IMMUNOGENET, 16 (2), 177-183
  3. Brinchmann JE, Leivestad T, Vartdal F (1989)
    Quantification of lymphocyte subsets based on positive immunomagnetic selection of cells directly from blood
    16 (2), 177-83
    PubMed 2687388
  4. BRINCHMANN JE, VARTDAL F, THORSBY E (1989)
    LYMPHOCYTE-T SUBSET CHANGES IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 2 (4), 398-403
  5. Brinchmann JE, Vartdal F, Thorsby E (1989)
    T lymphocyte subset changes in human immunodeficiency virus infection
    J Acquir Immune Defic Syndr, 2 (4), 398-403
    PubMed 2526872
  6. Kolstad A, Hannestad K, Vandvik B, Vartdal F (1989)
    Multiple sclerosis patients have a high frequency of an HLA-DQ beta epitope defined by a human-human hybridoma antibody
    33 (5), 546-9
    DOI 10.1111/j.1399-0039.1989.tb01706.x, PubMed 2477915
  7. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E (1989)
    Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer
    169 (1), 345-50
    DOI 10.1084/jem.169.1.345, PubMed 2909659
  8. Thorsby E, Lundin KE, Rønningen KS, Sollid LM, Vartdal F (1989)
    Molecular basis and functional importance of some disease-associated HLA polymorphisms
    34 (1), 39-49
    DOI 10.1111/j.1399-0039.1989.tb01716.x, PubMed 2683208
  9. Vartdal F (1989)
    HLA associations in multiple sclerosis: implications for immunopathogenesis
    Res Immunol, 140 (2), 192-6; discussion 245-8
    DOI 10.1016/0923-2494(89)90085-0, PubMed 2500681
  10. Vartdal F, Rønningen KS, Sollid LM, Thorsby E (1989)
    [Gene technology in immunologic research, diagnosis and treatment]
    109 (30), 3111-4
    PubMed 2683198
  11. Vartdal F, Sollid LM, Vandvik B, Markussen G, Thorsby E (1989)
    Patients with multiple sclerosis carry DQB1 genes which encode shared polymorphic amino acid sequences
    25 (2), 103-10
    DOI 10.1016/0198-8859(89)90074-8, PubMed 2737928

Publications 1988

  1. Brinchmann JE, Vartdal F, Forset KL, Thorsby E (1988)
    Immunologic monitoring of rabbit antithymocyte globulin-treated transplant recipients: a comparison of serial E-RFC and immunomagnetic quantitation of CD2+ cells
    20 (3), 390-1
    PubMed 3289168
  2. BRINCHMANN JE, VARTDAL F, FORSET KL, THORSBY E (1988)
    IMMUNOLOGICAL MONITORING OF RABBIT ANTITHYMOCYTE GLOBULIN-TREATED TRANSPLANT RECIPIENTS - A COMPARISON OF SERIAL E-RFC AND IMMUNOMAGNETIC QUANTITATION OF CD2+ CELLS
    Transplant. Proc., 20 (3), 390-391
  3. BRINCHMANN JE, VARTDAL F, FORSET KL, THORSBY E (1988)
    A COMPARISON OF SERIAL E-RFC MONITORING AND IMMUNOMAGNETIC QUANTITATION OF CD2+ CELLS IN RATG-TREATED TRANSPLANT RECIPIENTS
    Transplantation, 45 (4), 804-805
  4. Brinchmann JE, Vartdal F, Forset KL, Thorsby E (1988)
    A comparison of serial E-RFC monitoring and immunomagnetic quantitation of CD2+ cells in RATG-treated transplant recipients
    45 (4), 804-5
    PubMed 2895968
  5. BRINCHMANN JE, VARTDAL F, GAUDERNACK G, MARKUSSEN G, FUNDERUD S, UGELSTAD J, THORSBY E (1988)
    DIRECT IMMUNOMAGNETIC QUANTIFICATION OF LYMPHOCYTE SUBSETS IN BLOOD
    Clin. Exp. Immunol., 71 (1), 182-186
  6. Brinchmann JE, Vartdal F, Gaudernack G, Markussen G, Funderud S, Ugelstad J, Thorsby E (1988)
    Direct immunomagnetic quantification of lymphocyte subsets in blood
    71 (1), 182-6
    PubMed 3349645
  7. Lea T, Vartdal F, Nustad K, Funderud S, Berge A, Ellingsen T, Schmid R, Stenstad P, Ugelstad J (1988)
    Monosized, magnetic polymer particles: their use in separation of cells and subcellular components, and in the study of lymphocyte function in vitro
    J Mol Recognit, 1 (1), 9-18
    DOI 10.1002/jmr.300010104, PubMed 3078840
  8. Lie O, Vartdal F, Funderud S, Gaudernack G, Olsaker I, Frøysadal E, Ugelstad J, Thorsby E (1988)
    Immunomagnetic isolation of cells for serological BoLA typing
    Anim Genet, 19 (2), 75-86
    DOI 10.1111/j.1365-2052.1988.tb00794.x, PubMed 3137848
  9. LIE O, VARTDAL F, OLSAKER L, FROYSADAL E, SORENSEN A, UGELSTAD J (1988)
    BOLA CLASS-II TYPING OF CELL-POPULATIONS PREPARED WITH IMMUNOMAGNETIC BEADS USING INTERSPECIES CROSSREACTIVE REAGENTS
    Anim. Genet., 19 1, 15-17
  10. Lund A, Hellemann AL, Vartdal F (1988)
    Rapid isolation of K88+ Escherichia coli by using immunomagnetic particles
    26 (12), 2572-5
    PubMed 3068250
  11. LUND A, HELLEMANN AL, VARTDAL F (1988)
    RAPID ISOLATION OF K88+ ESCHERICHIA-COLI BY USING IMMUNOMAGNETIC PARTICLES
    J. Clin. Microbiol., 26 (12), 2572-2575
  12. UGELSTAD J, BERGE A, ELLINGSEN T, AUNE O, KILAAS L, NILSEN TN, SCHMID R, STENSTAD P, FUNDERUD S, KVALHEIM G, NUSTAD K, LEA T, VARTDAL F, DANIELSEN H (1988)
    MONOSIZED MAGNETIC PARTICLES AND THEIR USE IN SELECTIVE CELL-SEPARATION
    MAKROMOL CHEM-M SYMP, 17, 177-211
  13. VARTDAL F, BRATLIE A, THORSBY E (1988)
    IMMUNOMAGNETIC TISSUE TYPING OFFERS NEW POSSIBILITIES IN CADAVERIC TRANSPLANT DONOR-RECIPIENT HLA MATCHING
    Transplant. Proc., 20 (3), 384
  14. Vartdal F, Bratlie A, Thorsby E (1988)
    Immunomagnetic tissue typing offers new possibilities in cadaveric transplant donor-recipient HLA matching
    20 (3), 384
    PubMed 3381253

Publications 1987

  1. Halvorsen R, Gaudernack G, Leivestad T, Vartdal F, Thorsby E (1987)
    Activation of resting, pure CD4+, and CD8+ cells via CD3. Requirements for second signals
    26 (2), 197-205
    DOI 10.1111/j.1365-3083.1987.tb02252.x, PubMed 2957786
  2. LEIVESTAD T, GAUDERNACK G, UGELSTAD J, VARTDAL F, THORSBY E (1987)
    ISOLATION OF PURE AND FUNCTIONALLY ACTIVE T4 AND T8 CELLS BY POSITIVE SELECTION WITH ANTIBODY-COATED MONOSIZED MAGNETIC MICROSPHERES
    Transplant. Proc., 19 (1), 265-267
  3. Leivestad T, Gaudernack G, Ugelstad J, Vartdal F, Thorsby E (1987)
    Isolation of pure and functionally active T4 and T8 cells by positive selection with antibody-coated monosized magnetic microspheres
    19 (1 Pt 1), 265-7
    PubMed 3152700
  4. Mollnes TE, Vandvik B, Lea T, Vartdal F (1987)
    Intrathecal complement activation in neurological diseases evaluated by analysis of the terminal complement complex
    78 (1), 17-28
    DOI 10.1016/0022-510x(87)90074-8, PubMed 3572448
  5. VARTDAL F, ALBRECHTSEN D, RINGDEN O, KVALHEIM G, LEA T, BOSNES V, GAUDERNACK G, BRINCHMANN J, UGELSTAD J (1987)
    IMMUNOMAGNETIC TREATMENT OF BONE-MARROW ALLOGRAFTS
    Bone Marrow Transplant., 2 2, 94-98
  6. VARTDAL F, BRATLIE A, GAUDERNACK G, FUNDERUD S, LEA T, THORSBY E (1987)
    MICROCYTOTOXIC HLA TYPING OF CELLS DIRECTLY ISOLATED FROM BLOOD BY MEANS OF ANTIBODY-COATED MICROSPHERES
    Transplant. Proc., 19 (1), 655-657
  7. Vartdal F, Bratlie A, Gaudernack G, Funderud S, Lea T, Thorsby E (1987)
    Microcytotoxic HLA typing of cells directly isolated from blood by means of antibody-coated microspheres
    19 (1 Pt 1), 655-7
    PubMed 3152705
  8. Vartdal F, Kvalheim G, Lea TE, Bosnes V, Gaudernack G, Ugelstad J, Albrechtsen D (1987)
    Depletion of T lymphocytes from human bone marrow. Use of magnetic monosized polymer microspheres coated with T-lymphocyte-specific monoclonal antibodies
    43 (3), 366-71
    PubMed 3103274
  9. VARTDAL F, KVALHEIM G, LEA TE, BOSNES V, GAUDERNACK G, UGELSTAD J, ALBRECHTSEN D (1987)
    DEPLETION OF LYMPHOCYTES-T FROM HUMAN-BONE MARROW - USE OF MAGNETIC MONOSIZED POLYMER MICROSPHERES COATED WITH LYMPHOCYTE-T-SPECIFIC MONOCLONAL-ANTIBODIES
    Transplantation, 43 (3), 366-371

Publications 1986

  1. LEA T, SMELAND E, FUNDERUD S, VARTDAL F, DAVIES C, BEISKE K, UGELSTAD J (1986)
    CHARACTERIZATION OF HUMAN MONONUCLEAR-CELLS AFTER POSITIVE SELECTION WITH IMMUNOMAGNETIC PARTICLES
    Scand. J. Immunol., 23 (4), 509-519
  2. Lea T, Smeland E, Funderud S, Vartdal F, Davies C, Beiske K, Ugelstad J (1986)
    Characterization of human mononuclear cells after positive selection with immunomagnetic particles
    23 (4), 509-19
    DOI 10.1111/j.1365-3083.1986.tb03083.x, PubMed 2422741
  3. Rognum TO, Vartdal F, Rodahl K, Opstad PK, Knudsen-Baas O, Kindt E, Withey WR (1986)
    Physical and mental performance of soldiers on high- and low-energy diets during prolonged heavy exercise combined with sleep deprivation
    29 (7), 859-67
    DOI 10.1080/00140138608967198, PubMed 3743541
  4. Stavem P, Abrahamsen AF, Vartdal F, Nordhagen R, Rootwelt K (1986)
    Hereditary thrombocytopenia with excessively prolonged bleeding time, corrected by infusions of platelet poor plasma
    37 (3), 210-4
    DOI 10.1111/j.1600-0609.1986.tb02299.x, PubMed 3787172
  5. STAVEM P, ABRAHAMSEN AF, VARTDAL F, NORDHAGEN R, ROOTWELT K (1986)
    HEREDITARY THROMBOCYTOPENIA WITH EXCESSIVELY PROLONGED BLEEDING-TIME, CORRECTED BY INFUSIONS OF PLATELET POOR PLASMA
    SCAND J HAEMATOL, 37 (3), 210-214
  6. VARTDAL F, GAUDERNACK G, FUNDERUD S, BRATLIE A, LEA T, UGELSTAD J, THORSBY E (1986)
    HLA CLASS-I AND CLASS-II TYPING USING CELLS POSITIVELY SELECTED FROM BLOOD BY IMMUNOMAGNETIC ISOLATION - A FAST AND RELIABLE TECHNIQUE
    Tissue Antigens, 28 (5), 301-312
  7. Vartdal F, Gaudernack G, Funderud S, Bratlie A, Lea T, Ugelstad J, Thorsby E (1986)
    HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique
    28 (5), 301-12
    DOI 10.1111/j.1399-0039.1986.tb00500.x, PubMed 3469787
  8. Vartdal F, Vandvik B, Lea T (1986)
    Immunofluorescence staining of agarose-embedded cells. A new technique developed for immunological characterization of markers on a small number of cells
    92 (1), 125-9
    DOI 10.1016/0022-1759(86)90512-0, PubMed 3528296
  9. Walker MR, Bird P, Ulaeto DO, Vartdal F, Goodall DM, Jefferis R (1986)
    Immunogenic and antigenic epitopes of immunoglobulins. XIV. Antigenic variants of IgG4 proteins revealed with monoclonal antibodies
    57 (1), 25-8
    PubMed 2417939
  10. WALKER MR, BIRD P, ULAETO DO, VARTDAL F, GOODALL DM, JEFFERIS R (1986)
    IMMUNOGENIC AND ANTIGENIC EPITOPES OF IMMUNOGLOBULINS .14. ANTIGENIC VARIANTS OF IGG4 PROTEINS REVEALED WITH MONOCLONAL-ANTIBODIES
    Immunology, 57 (1), 25-28

Publications 1985

  1. Lea T, Vartdal F, Davies C, Ugelstad J (1985)
    Magnetic monosized polymer particles for fast and specific fractionation of human mononuclear cells
    22 (2), 207-16
    DOI 10.1111/j.1365-3083.1985.tb01873.x, PubMed 3875896

Publications 1984

  1. Mellbye OJ, Vartdal F, Dobloug JH (1984)
    Subclasses of IgG produced in the rheumatoid synovium
    Rheumatol Int, 4 Suppl, 49-52
    DOI 10.1007/BF00541279, PubMed 6336226

Publications 1983

  1. Nordal HJ, Aarli JA, Nyland H, Vartdal F (1983)
    [Immunomodulated treatment of neurologic diseases]
    103 (30), 2033-8
    PubMed 6658725
  2. Vartdal F, Bird P (1983)
    Imprint immunofixation of IgG subclasses, using monoclonal subclass-specific antibodies
    18 (4), 367-70
    DOI 10.1111/j.1365-3083.1983.tb01809.x, PubMed 6648366
  3. VARTDAL F, VANDVIK B (1983)
    MULTIPLE-SCLEROSIS - SUBCLASSES OF INTRATHECALLY SYNTHESIZED IGG AND MEASLES AND VARICELLA ZOSTER VIRUS IGG ANTIBODIES
    Clin. Exp. Immunol., 54 (3), 641-647
  4. Vartdal F, Vandvik B (1983)
    Multiple sclerosis: subclasses of intrathecally synthesized IgG and measles and varicella zoster virus IgG antibodies
    54 (3), 641-7
    PubMed 6317243
  5. Vartdal F, Vandvik B (1983)
    Characterization of classes of intrathecally synthesized antibodies by imprint immunofixation of electrophoretically separated sera and cerebrospinal fluids
    Acta Pathol Microbiol Immunol Scand C, 91 (1), 69-75
    PubMed 6869017
  6. Vartdal F, Vandvik B (1983)
    Imprint immunofixation of electrofocused immunoglobulins
    62 (1), 23-9
    DOI 10.1016/0022-1759(83)90106-0, PubMed 6409963

Publications 1982

  1. Vandvik B, Nilsen RE, Vartdal F, Norrby E (1982)
    Mumps meningitis: specific and non-specific antibody responses in the central nervous system
    65 (5), 468-87
    DOI 10.1111/j.1600-0404.1982.tb03104.x, PubMed 7051738
  2. Vandvik B, Vartdal F, Norrby E (1982)
    Herpes simplex virus encephalitis: intrathecal synthesis of oligoclonal virus-specific IgG, IgA and IgM antibodies
    228 (1), 25-38
    DOI 10.1007/bf00313407, PubMed 6184456
  3. Vartdal F, Vandvik B (1982)
    Multiple sclerosis. Electrofocused "bands" of oligoclonal CSF IgG do not carry antibody activity against measles, varicella-zoster or rotaviruses
    54 (1), 99-107
    DOI 10.1016/0022-510x(82)90222-2, PubMed 6281394
  4. Vartdal F, Vandvik B, Michaelsen TE, Loe K, Norrby E (1982)
    Neurosyphilis: intrathecal synthesis of oligoclonal antibodies to Treponema pallidum
    11 (1), 35-40
    DOI 10.1002/ana.410110107, PubMed 7036846
  5. Vartdal F, Vandvik B, Norrby E (1982)
    Intrathecal synthesis of virus-specific oligoclonal IgG, IgA and IgM antibodies in a case of varicella-zoster meningoencephalitis
    57 (1), 121-32
    DOI 10.1016/0022-510x(82)90116-2, PubMed 6296323

Publications 1981

  1. Togashi T, Orvell C, Vartdal F, Norrby E (1981)
    Production of antibodies against measles virions by use of the mouse hybridoma technique
    67 (2), 149-57
    DOI 10.1007/bf01318598, PubMed 7011259

Publications 1980

  1. Vartdal F, Vandvik B, Norrby E (1980)
    Viral and bacterial antibody responses in multiple sclerosis
    8 (3), 248-55
    DOI 10.1002/ana.410080305, PubMed 6254433
 
Page visits: 3352